pirenzepine has been researched along with Fistula in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, VM | 1 |
| Vanhoutte, PM | 1 |
1 other study available for pirenzepine and Fistula
| Article | Year |
|---|---|
Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Calcimycin; Dogs; Endothelium, Vascular; Femoral Arte | 1988 |